Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2 in the footer, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:25:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The banner about a lapse in government funding has been removed from the page. This notice did not affect the study details or participation requirements.
    Difference
    0.4%
    Check dated 2025-11-17T19:18:02.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Results have been posted (Results First Posted 2025-07-20) with updated primary and secondary outcomes and safety data.
    Difference
    0.5%
    Check dated 2025-11-03T13:17:16.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.
    Difference
    3%
    Check dated 2025-10-06T04:15:13.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.1%
    Check dated 2025-09-28T23:33:35.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The Back to Top link was removed; no other substantive changes were detected.
    Difference
    0.2%
    Check dated 2025-09-14T09:46:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.